Methanol extract of Codium fragile inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 and invasiveness of MDA-MB-231 cells by suppressing nuclear factor-κB activation

被引:12
作者
Dilshara, Matharage Gayani [1 ]
Jayasooriya, Rajapaksha Gedara Prasad Tharanga [1 ]
Kang, Chang-Hee [1 ,2 ]
Choi, Yung-Hyun [3 ]
Kim, Gi-Young [1 ]
机构
[1] Jeju Natl Univ, Dept Marine Life Sci, Jeju Si 63243, South Korea
[2] Nakdonggang Natl Inst Biol Resource, Sangju Si 37242, Gyeongsangbuk D, South Korea
[3] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Busan 47340, South Korea
基金
新加坡国家研究基金会;
关键词
Codium fragile; Invasion; Nuclear factor-kappa B; Matrix metalloproteinase-9; Tumor necrosis factor-alpha; BREAST-CANCER; MATRIX METALLOPROTEINASES; MMP-9; EXPRESSION; CARCINOMA; TRANSCRIPTION; PROGRESSION; INFLIXIMAB; INVASION; PATHWAY; GROWTH;
D O I
10.1016/j.apjtm.2016.04.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To evaluate whether the methanol extract of Codium fragile (MECF) regulates tumor necrosis factor-alpha (TNF-alpha)-induced invasion of human breast cancer MDA-MB-231 cells by suppressing matrix metalloproteinase-9 (MMP-9). Methods: Reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis were performed to analyze the expression of MMP-9 and nuclear factor-kappa B (NF-kappa B) subunits, p65 and p50, and I kappa B in MDA-MB-231 cells. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used for cell viability. MMP-9 activity and invasion were measured by gelatin zymography and a matrigel invasion assay, respectively. NF-kappa B activity was measured by an electrophoretic mobility shift assay and luciferase activity. Results: MECF had no effect on cell viability up to a concentration of 100 mg/mL in human breast cancer MDA-MB-231 cells regardless of the presence of TNF-alpha. MDA-MB-231 cells that were stimulated with TNF-alpha showed a marked increase of invasion compared to the untreated control, whereas pretreatment with MECF downregulated the TNF-alpha-induced invasion of MDA-MB-231 cells. Additionally, zymography, western blot analysis, and RT-PCR confirmed that MECF decreased TNF-alpha-induced MMP-9 expression and activity which is a key regulator for cancer invasion. According to an electrophoretic morbidity shift assay, pretreatment with MECF in MDA-MB-231 cells significantly decreased the TNF-alpha-induced DNA-binding activity of NF-kappa B, which is an important transcription factor for regulating cancer invasion-related genes such as MMP-9. Furthermore, treatment with MECF sustained the expression of p65 and p50 in response to TNF-alpha in the cytosolic compartment. The luciferase assay demonstrated that MECF attenuated TNF-alpha-induced NF-kappa B luciferase activity. Conclusion: MECF exhibited its anti-invasive capability by downregulating TNF-alpha-induced MMP-9 expression, resulting from the suppression of NF-kappa B activity in the human breast cancer cell line MDA-MB-231.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 27 条
[1]   Leukemia virus long terminal repeat activates NFκB pathway by a TLR3-dependent mechanism [J].
Abujamra, AL ;
Spanjaard, RA ;
Akinsheye, I ;
Zhao, XS ;
Faller, DV ;
Ghosh, SK .
VIROLOGY, 2006, 345 (02) :390-403
[2]   Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer -: MMP-9 correlates to the grade and the stage [J].
Aglund, K ;
Rauvala, M ;
Puistola, U ;
Ångström, T ;
Turpeenniemi-Hujanen, T ;
Zackrisson, B ;
Stendahl, U .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :699-704
[3]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[4]   Exploitation of marine algae: biogenic compounds for potential antifouling applications [J].
Bhadury, P ;
Wright, PC .
PLANTA, 2004, 219 (04) :561-578
[5]   A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer [J].
Brown, E. R. ;
Charles, K. A. ;
Hoare, S. A. ;
Rye, R. L. ;
Jodrell, D. I. ;
Aird, R. E. ;
Vora, R. ;
Prabhakar, U. ;
Nakada, M. ;
Corringham, R. E. ;
DeWitte, M. ;
Sturgeon, C. ;
Propper, D. ;
Balkwill, F. R. ;
Smyth, J. F. .
ANNALS OF ONCOLOGY, 2008, 19 (07) :1340-1346
[6]   NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells [J].
Chen, Ying-Jung ;
Chang, Long-Sen .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (10) :1248-1259
[7]   Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway [J].
Cheng, J. C-H ;
Chou, C. H. ;
Kuo, M. L. ;
Hsieh, C-Y .
ONCOGENE, 2006, 25 (53) :7009-7018
[8]   Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells [J].
Dahl, Karen D. Cowden ;
Symowicz, Jaime ;
Ning, Yan ;
Gutierrez, Elisa ;
Fishman, David A. ;
Adley, Brian P. ;
Stack, M. Sharon ;
Hudson, Laurie G. .
CANCER RESEARCH, 2008, 68 (12) :4606-4613
[9]   Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells [J].
Ganesan, Ponesakki ;
Noda, Kenji ;
Manabe, Yuki ;
Ohkubo, Takeshi ;
Tanaka, Yukihisa ;
Maoka, Takashi ;
Sugawara, Tatsuya ;
Hirata, Takashi .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2011, 1810 (05) :497-503
[10]   Tumor necrosis factor α as a new target for renal cell carcinoma:: Two sequential phase II trials of infliximab at standard and high dose [J].
Harrison, Michelle L. ;
Obermueller, Eva ;
Maisey, Nick R. ;
Hoare, Susan ;
Edmonds, Kim ;
Li, Ningfeng F. ;
Chao, David ;
Hall, Kate ;
Lee, Chooi ;
Timotheadou, Eleni ;
Charles, Kellie ;
Ahern, Roger ;
King, D. Mike ;
Eisen, Tim ;
Corringham, Robert ;
DeWitte, Mark ;
Balkwill, Frances ;
Gore, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4542-4549